Correlation Between Inhibrx and Eltek
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Eltek at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Eltek into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Eltek, you can compare the effects of market volatilities on Inhibrx and Eltek and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Eltek. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Eltek.
Diversification Opportunities for Inhibrx and Eltek
Very good diversification
The 3 months correlation between Inhibrx and Eltek is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Eltek in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eltek and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Eltek. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eltek has no effect on the direction of Inhibrx i.e., Inhibrx and Eltek go up and down completely randomly.
Pair Corralation between Inhibrx and Eltek
Given the investment horizon of 90 days Inhibrx is expected to under-perform the Eltek. But the stock apears to be less risky and, when comparing its historical volatility, Inhibrx is 1.44 times less risky than Eltek. The stock trades about -0.04 of its potential returns per unit of risk. The Eltek is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 1,092 in Eltek on September 26, 2024 and sell it today you would earn a total of 8.00 from holding Eltek or generate 0.73% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Inhibrx vs. Eltek
Performance |
Timeline |
Inhibrx |
Eltek |
Inhibrx and Eltek Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inhibrx and Eltek
The main advantage of trading using opposite Inhibrx and Eltek positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Eltek can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eltek will offset losses from the drop in Eltek's long position.Inhibrx vs. Fate Therapeutics | Inhibrx vs. Caribou Biosciences | Inhibrx vs. Karyopharm Therapeutics | Inhibrx vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
CEOs Directory Screen CEOs from public companies around the world | |
Stocks Directory Find actively traded stocks across global markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |